Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors

J Priller, E M Briley, J Mansouri, W A Devane, K Mackie, C C Felder

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors'. Together they form a unique fingerprint.

Medicine & Life Sciences